MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Medline Inc.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)
Close on Oct 19, 2026
- Market cap
- $30.29B
- P/E (TTM)
- –
- Dividend yield
- –
Medline Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Supply Chain Solutions | $4.15B | $3.89B | – | $3.56B | $3.38B | – | 53.9% | +16.3% |
| Medline Brand | $3.54B | $3.47B | – | $3.32B | $3.26B | – | 46.1% | +6.6% |
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q2 25 | Q1 25 | Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $7.15B | $6.86B | – | $6.40B | $6.19B | – | 93.1% | +11.8% |
| International | $533.00M | $495.00M | – | $487.00M | $450.00M | – | 6.9% | +9.4% |
From the segment and revenue-disaggregation notes of Medline's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.